Assessing the Efficacy and Safety of Selective Serotonin Reuptake Inhibitors for Managing COVID-19 Patients: A Systematic Review and Meta-Analysis
B61. MORE OF COVID-19 | May 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: A3855-A3855
10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3855